Synthesis of novel fluorescent probes for the molecular chaperone Hsp90

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 22, 2003, Pages 3975-3978

  Llauger Bufi, Laura ^a   Felts, Sara J ^b   Huezo, Henri ^a   Rosen, Neal ^a   Chiosis, Gabriela ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; FLUORESCEIN DERIVATIVE; GELDANAMYCIN; HEAT SHOCK PROTEIN 90;

ARTICLE; CHEMICAL MODIFICATION; LIGAND BINDING; MICHAEL ADDITION; PROTEIN PROTEIN INTERACTION; SYNTHESIS;

EID: 0242285605     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.08.065     Document Type: Article

References (27)

1. Scheibel T., Buchner J. Biochem. Pharmacol. 56:1998;675.
2. Buchner J. Trends Biochem. Sci. 4:1999;136.
3. Toft O.D. Trends Endocrinol. Metab. 9:1998;238.
4. Neckers L. Trends Mol. Med. 8:2002;S55.
5. Workman P., Maloney A. Expert Opin. Biol. Ther. 2:2002;3.
6. Stebbins C.E., Russo A.A., Schneider C., Rosen N., Hartl F.U., Pavletich N.P. Cell. 89:1997;239.
7. Roe S.M., Prodromou C., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. J. Med. Chem. 42:1999;260.
8. Prodromou C., Roe S.M., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. Cell. 90:1997;65.
9. Obermann W.M., Sondermann H., Russo A.A., Pavletich N.P., Hartl F.U. J. Cell Biol. 143:1998;901.
10. Prodromou C., Panaretou B., Chohan S., Siligardi G., O'Brien R., Ladbury J.E., Roe S.M., Piper P.W., Pearl L.H. EMBO J. 19:2000;4383.
11. Whitesell L., Mimnaugh E.G., De Costa B., Myers C.E., Neckers L.M. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8324.
12. Xu W., Mimnaugh E., Rosser M.F., Nicchitta C., Marcu M., Yarden Y., Neckers L. J. Biol. Chem. 276:2001;3702.
13. Chiosis G., Lucas B., Shtil A., Huezo H., Rosen N. Bioorg. Med. Chem. 1:2002;3555.
14. Roe S.M., Prodromou C., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. J. Med. Chem. 42:1999;260.
15. Prodromou C., Siligardi G., O'Brien R., Woolfson D.N., Regan L., Panaretou B., Ladbury J.E., Piper P.W., Pearl L.H. EMBO J. 18:1999;754.
16. Panaretou B., Prodromou C., Roe S.M., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. EMBO J. 17:1998;4829.
17. Obermann W.M., Sondermann H., Russo A.A., Pavletich N.P., Hartl F.U. J. Cell Biol. 143:1998;901.
18. Richter K., Muschler P., Hainzl O., Buchner J. J. Biol. Chem. 276:2001;33689.
19. Weikl T., Muschler P., Richter K., Veit T., Reinstein J., Buchner J. J. Mol. Biol. 303:2000;583.
20. Carreras C.W., Schirmer A., Zhong Z., Santi D.V. Anal. Biochem. 317:2003;40.
21. Lakowicz J. In Principles of Fluorescence Spectroscopy. 2nd ed. 1999;Kluwer academic/Plenum, New York.
22. Neckers L., Schulte T.W., Mimnaugh E. Invest. New Drugs. 17:1999;361.
23. 3): δ 9.12 (s, 1H), 7.19 (s, 1H), 7.04 (s, 1H), 6.95-6.93 (m, 1H), 6.81 (d, J=3.8 Hz, 1H), 6.60-6.55 (m, 2H), 6.24-6.23 (m, 2H), 6.11 (s, 1H), 5.92-5.82 (m, 2H), 5.17 (s, 1H), 4.75 (bs, 2H), 4.37-4.28 (m, 2H), 3.57-3.44 (m, 5H), 3.34 (s, 3H), 3.28 (s, 3H), 3.27-3.22 (m, 2H), 2.75-2. 69 (m, 2H), 2.54 (s, 3H), 2.32-2.30 (m, 1H), 2.29 (s, 3H), 2.03 (s, 3H), 1.86 (s, 3H), 1.72-1.69 (m, 1H), 1.56-1.52 (m, 1H), 0.98 (d, J=6.8 Hz, 3H), 0.92 (d, J=6.6 Hz, 3H). MS m/z 885.4 (M+Na).
24. Schnur R.C., Corman M.L., Gallaschun R.J., Cooper B.A., Dee M.F., Doty J.L., Muzzi M.L., Moyer J.D., DiOrio C.I., Barbacci E.G., Miller P.E., O'Brien A.T., Morin M.J., Foster B.A., Pollack V.A., Savage D.M., Sloan D.E., Pustilnik L.R., Moyer M.P. J. Med. Chem. 38:1995;3806.
25. Schnur R.C., Corman M.L., Gallaschun R.J., Cooper B.A., Dee M.F., Doty J.L., Mumi M.L., DiOrio C.I., Barbacci E.G., Miller P.E., Pollack V.A., Savage D.M., Sloan D.E., Pustilnik L.R., Moyer J.D., Moyer M.P. J. Med. Chem. 38:1996;3813.
26. Schulte T.W., Neckers L.M. Cancer Chemother. Pharmacol. 42:1998;273.
27. Chiosis G., Timaul M.N., Lucas B., Munster M.N., Zheng F.F., Sepp-Lorenzino L., Rosen N. Chem. Biol. 8:2001;289.